The online versions of legislation provided on this website are not official. Enrolled bills are the final version passed by the Ohio General Assembly and presented to the Governor for signature. The official version of acts signed by the Governor are available from the Secretary of State's Office in the Continental Plaza, 180 East Broad St., Columbus.
|
***
An attempt was made to recreate these historic documents. The original text was retained, however, during the process some errors in formatting may have been introduced. The official version of the act may be obtained from the Secretary of State's Office listed above.
***
|
(123rd General Assembly)(Amended House Bill Number 428)
AN ACT
To amend section 3719.41 of the Revised Code to make gamma-hydroxy-butyrate a
schedule II controlled substance and to revise the state
controlled substances schedules according to federal drug laws.
Be it enacted by the General Assembly of the State of Ohio:
SECTION 1 . That section 3719.41 of the Revised Code be amended to read as
follows:
Sec. 3719.41. Controlled substance schedules I, II, III,
IV, and V are hereby established, which schedules include the
following, subject to amendment pursuant to section 3719.43 or
3719.44 of the Revised Code. SCHEDULE I(A) Narcotics-opiates Any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters, and ethers,
unless specifically excepted under federal drug abuse control
laws, whenever the existence of these isomers, esters, ethers,
and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl
(N-[-1[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (2) Acetylmethadol; (3) Allylprodine; (4) Alphacetylmethadol (except levo-alphacetyl-methadol
levo-alphacetylmethadol, also known as
levo-alpha-acetyl-methadol levo-alpha-acetylmethadol,
levomethadyl acetate, or LAAM); (5) Alphameprodine; (6) Alphamethadol; (7) Alpha-methylfentanyl
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)
piperidine); (8) Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide); (9) Benzethidine; (10) Betacetylmethadol; (11) Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-N-
phenylpropanamide); (12) Beta-hydroxy-3-methylfentanyl (other name:
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-
phenylpropanamide); (13) Betameprodine; (14) Betamethadol; (15) Betaprodine; (16) Clonitazene; (17) Dextromoramide; (18) Diampromide; (19) Diethylthiambutene; (20) Difenoxin; (21) Dimenoxadol; (22) Dimepheptanol; (23) Dimethylthiambutene; (24) Dioxaphetyl butyrate; (25) Dipipanone; (26) Ethylmethylthiambutene; (27) Etonitazene; (28) Etoxeridine; (29) Furethidine; (30) Hydroxypethidine; (31) Ketobemidone; (32) Levomoramide; (33) Levophenacylmorphan; (34) 3-methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-
phenylpropanamide); (35) 3-methylthiofentanyl
(N-[3-methyl-1-[2-(thienyl)ethyl]-4-piperidinyl]-N-
phenylpropanamide); (36) Morpheridine; (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); (38) Noracymethadol; (39) Norlevorphanol; (40) Normethadone; (41) Norpipanone; (42) Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide; (43) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine; (44) Phenadoxone; (45) Phenampromide; (46) Phenomorphan; (47) Phenoperidine; (48) Piritramide; (49) Proheptazine; (50) Properidine; (51) Propiram; (52) Racemoramide; (53) Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide; (54) Tilidine; (55) Trimeperidine. (B) Narcotics-opium derivatives Any of the following opium derivatives, including their salts,
isomers, and salts of isomers, unless specifically excepted under
federal drug abuse control laws, whenever the existence of these
salts, isomers, and salts of isomers is possible within the
specific chemical designation: (1) Acetorphine; (2) Acetyldihydrocodeine; (3) Benzylmorphine; (4) Codeine methylbromide; (5) Codeine-n-oxide; (6) Cyprenorphine; (7) Desomorphine; (8) Dihydromorphine; (9) Drotebanol; (10) Etorphine (except hydrochloride salt); (11) Heroin; (12) Hydromorphinol; (13) Methyldesorphine; (14) Methyldihydromorphine; (15) Morphine methylbromide; (16) Morphine methylsulfonate; (17) Morphine-n-oxide; (18) Myrophine; (19) Nicocodeine; (20) Nicomorphine; (21) Normorphine; (22) Pholcodine; (23) Thebacon. (C) Hallucinogens Any material, compound, mixture, or preparation that
contains any quantity of the following hallucinogenic substances,
including their salts, isomers, and salts of isomers, unless
specifically
excepted under federal drug abuse control laws, whenever the
existence of these salts, isomers, and salts of isomers is
possible within the specific chemical designation. For the
purposes of this division only, "isomer" includes the
optical isomers, position isomers, and geometric isomers. (1) Alpha-ethyltryptamine (some trade or other names: etryptamine;
Monase; alpha-ethyl-1H-indole-3-ethanamine;
3-(2-aminobutyl) indole; alpha-ET; and AET); (2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other
names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine;
4-bromo-2,5-DMA); (2)(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or
other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl
DOB; 2C-B, Nexus);
(4) 2,5-dimethoxyamphetamine (some trade or other names:
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); (3)(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other
names: DOET);
(4)(6) 4-methoxyamphetamine (some trade or other names:
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
PMA);
(5)(7) 5-methoxy-3,4-methylenedioxy-amphetamine;
(6)(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or
other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine;
"DOM" and "STP");
(7)(9) 3,4-methylenedioxy amphetamine;
(8)(10) 3,4-methylenedioxymethamphetamine (MDMA);
(9)(11) 3,4-methylenedioxy-N-ethylamphetamine (also known as
N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl
MDA, MDE, MDEA);
(10)(12) N-hydroxy-3,4-methylenedioxyamphetamine (also known
as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and
N-hydroxy MDA);
(11)(13) 3,4,5-trimethoxy amphetamine;
(12)(14) Bufotenine (some trade or other names:
3-(beta-dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine);
(13)(15) Diethyltryptamine (some trade or other names: N,
N-diethyltryptamine; DET);
(14)(16) Dimethyltryptamine (some trade or other names:
DMT);
(15)(17) Ibogaine (some trade or other names:
7-ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-
5H-pyrido[1',2':1,2] azepino [5,4-B 4-b]
indole;
tabernanthe iboga);
(16)(18) Lysergic acid diethylamide;
(17)(19) Marihuana;
(18)(20) Mescaline;
(19)(21) Parahexyl (some trade or other names: 3-hexyl-1-
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
synhexyl);
(20)(22) Peyote (meaning all parts of the plant presently
classified botanically as "Lophophora williamsii Lemaire,"
whether growing or not, the seeds of that plant, any extract from
any part of that plant, and every compound, manufacture, salts,
derivative, mixture, or preparation of that plant, its seeds, or
its extracts);
(21)(23) N-ethyl-3-piperidyl benzilate;
(22)(24) N-methyl-3-piperidyl benzilate;
(23)(25) Psilocybin;
(24)(26) Psilocyn;
(25)(27) Tetrahydrocannabinols (synthetic equivalents of the
substances contained in the plant, or in the resinous extractives
of Cannabis, sp. and/or synthetic substances, derivatives, and
their isomers with similar chemical structure and pharmacological
activity such as the following: delta-1-cis or trans
tetrahydrocannabinol, and their optical isomers; delta-6-cis or
trans tetrahydrocannabinol, and their optical isomers;
delta-3,4-cis or trans tetrahydrocannabinol, and its optical
isomers. (Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions, are
covered.));
(26)(28) Ethylamine analog of phencyclidine (some trade or
other names: N-ethyl-1-phenylcyclohexylamine;
(1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;
cyclohexamine; PCE);
(27)(29) Pyrrolidine analog of phencyclidine (some trade or
other names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPY
PCPy; PHP);
(28)(30) Thiophene analog of phencyclidine (some trade or
other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl
analog of phencyclidine; TPCP; TCP);
(29)(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine;
(30)(32) Hashish.
(D) Depressants Any material, compound, mixture, or preparation that
contains any quantity of the following substances having a
depressant effect on the central nervous system, including their
salts, isomers, and salts of isomers, unless specifically
excepted under federal drug abuse control laws, whenever the
existence of these salts, isomers, and salts of isomers is
possible within the specific chemical designation: (1) Mecloqualone; (2) Methaqualone. (E) Stimulants Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation that
contains any quantity of the following substances having a
stimulant effect on the central nervous system, including their
salts, isomers, and salts of isomers: (1) Aminorex (some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
or 4,5-dihydro-5-phenyl-2-oxazolamine); (2) Cathinone (some trade or other names:
2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone,
and norephedrone); (3) Fenethylline; (4) Methcathinone (some other names: 2-(methylamino)-propiophenone;
alpha-(methylamino)propiophenone; 2-methylamino)-1-phenylpropan-1-one;
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432), its
salts, optical isomers, and salts of optical isomers; (5) (+/-)cis-4-methylaminorex
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine); (6) N-ethylamphetamine; (7) N,N-dimethylamphetamine (also known as
N,N-alpha-trimethyl-benzeneethanamine;
N,N-alpha-trimethylphenethylamine). SCHEDULE II(A) Narcotics-opium and opium derivatives Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any of the
following substances whether produced directly or indirectly by
extraction from substances of vegetable origin, independently by
means of chemical synthesis, or by a combination of extraction
and chemical synthesis: (1) Opium and opiate, and any salt, compound, derivative,
or preparation of opium or opiate, excluding apomorphine,
thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene,
naloxone, and naltrexone, and their respective salts, but
including the following: (a) Raw opium; (b) Opium extracts; (c) Opium fluid extracts; (d) Powdered opium; (e) Granulated opium; (f) Tincture of opium; (g) Codeine; (h) Ethylmorphine; (i) Etorphine hydrochloride; (j) Hydrocodone; (k) Hydromorphone; (l) Metopon; (m) Morphine; (n) Oxycodone; (o) Oxymorphone; (p) Thebaine. (2) Any salt, compound, derivative, or preparation thereof
that is chemically equivalent to or identical with any of the
substances referred to in division (A)(1) of this schedule,
except that these substances shall not include the isoquinoline
alkaloids of opium; (3) Opium poppy and poppy straw; (4) Coca leaves and any salt, compound, derivative, or
preparation of coca leaves (including cocaine and ecgonine, their
salts, isomers, and derivatives, and salts of those isomers and
derivatives), and any salt, compound, derivative, or preparation
thereof that is chemically equivalent to or identical with any of
these substances, except that the substances shall not include
decocainized coca leaves or extraction of coca leaves, which
extractions do not contain cocaine or ecgonine; (5) Concentrate of poppy straw (the crude extract of poppy
straw in either liquid, solid, or powder form that contains the
phenanthrene alkaloids of the opium poppy). (B) Narcotics-opiates Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any of the
following opiates, including their isomers, esters, ethers,
salts, and salts of isomers, esters, and ethers, whenever the
existence of these isomers, esters, ethers, and salts is possible
within the specific chemical designation, but excluding
dextrorphan and levopropoxyphene: (1) Alfentanil; (2) Alphaprodine; (3) Anileridine; (4) Bezitramide; (5) Bulk dextropropoxyphene (non-dosage forms); (6) Carfentanil; (7) Dihydrocodeine; (8) Diphenoxylate; (9) Fentanyl; (10) Isomethadone; (11) Levo-alphacetylmethadol (some other names:
levo-alpha-acetylmethadol,;
levomethadyl acetate; LAAM); (12) Levomethorphan; (13) Levorphanol; (14) Metazocine; (15) Methadone; (16) Methadone-intermediate,
4-cyano-2-dimethylamino-4,4-diphenyl butane; (17) Moramide-intermediate,
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid; (18) Pethidine (meperidine); (19) Pethidine-intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine; (20) Pethidine-intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate; (21) Pethidine-intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid; (22) Phenazocine; (23) Piminodine; (24) Racemethorphan; (25) Racemorphan; (26) Remifentanil; (27) Sufentanil. (C) Stimulants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances having a stimulant effect on the central
nervous system: (1) Amphetamine, its salts, its optical isomers, and salts
of its optical isomers; (2) Methamphetamine, its salts, its isomers, and salts of
its isomers; (3) Methylphenidate; (4) Phenmetrazine and its salts. (D) Depressants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances having a depressant effect on the
central nervous system, including their salts, isomers, and salts
of isomers, whenever the existence of these salts, isomers, and
salts of isomers is possible within the specific chemical
designation: (1) Amobarbital; (2) Gamma-hydroxy-butyrate; (3) Glutethimide; (3)(4) Pentobarbital;
(5) Phencyclidine (some trade or other names:
1-(1-phenylcyclohexyl)piperidine; PCP); (4) Pentobarbital;
(5)(6) Secobarbital;
(6)(7) 1-aminophenylcyclohexane and all N-mono-substituted
and/or all N-N-disubstituted analogs, including, but not
limited
to, the following:
(a) 1-phenylcyclohexylamine; (b) (1-phenylcyclohexyl) methylamine; (c) (1-phenylcyclohexyl) dimethylamine; (d) (1-phenylcyclohexyl) methylethylamine; (e) (1-phenylcyclohexyl) isopropylamine; (f) 1-(1-phenylcyclohexyl) morpholine. (E) Hallucinogenic substances (1) Dronabinol (synthetic) in sesame oil and encapsulated
in a soft gelatin capsule in a United States food and drug
administration approved drug product (some other names for
dronabinol: (6aR-trans)-6A,7,8,10a-tetrahydro-
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
(-)-delta-9-(trans)-tetrahydrocannabinol); (2) Nabilone (another name for nabilone:
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-
hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one).
(F) Immediate precursors Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances: (1) Immediate precursor to amphetamine and
methamphetamine: (a) Phenylacetone (some trade or other names:
phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
ketone); (2) Immediate precursors to phencyclidine (PCP): (a) 1-phenylcyclohexylamine; (b) 1-piperidinocyclohexanecarbonitrile (PCC). SCHEDULE III
(A) Stimulants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances having a stimulant effect on the central
nervous system, including their salts, their optical isomers,
position isomers, or geometric isomers, and salts of these
isomers, whenever the existence of these salts, isomers, and salts
of isomers is possible within the specific chemical designation: (1) All stimulant compounds, mixtures, and preparations
included in schedule III pursuant to the federal drug abuse
control laws and regulations adopted under those laws; (2) Benzphetamine; (3) Chlorphentermine; (4) Clortermine; (5) Phendimetrazine. (B) Depressants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances having a depressant effect on the
central nervous system: (1) Any compound, mixture, or preparation containing
amobarbital, secobarbital, pentobarbital, or any salt of any of
these drugs, and one or more other active medicinal ingredients
that are not listed in any schedule; (2) Any suppository dosage form containing amobarbital,
secobarbital, pentobarbital, or any salt of any of these drugs
and approved by the food and drug administration for marketing
only as a suppository; (3) Any substance that contains any quantity of a
derivative of barbituric acid or any salt of a derivative of
barbituric acid; (4) Chlorhexadol; (5) Ketamine, its salts, isomers, and salts of isomers (some other names
for ketamine: (+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone); (6) Lysergic acid; (6)(7) Lysergic acid amide;
(7)(8) Methyprylon;
(8)(9) Sulfondiethylmethane;
(9)(10) Sulfonethylmethane;
(10)(11) Sulfonmethane;
(11)(12) Tiletamine, zolazepam, or any salt of tiletamine or
zolazepam (some trade or other names for a tiletamine-zolazepam
combination product: Telazol); (some trade or other names for
tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some
trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-
dihydro-1,3,8-trimethylpyrazolo-[3,4-E
4-e][1,4]-diazepin-7(1H)-one;
flupyrazapon).
(C) Narcotic antidotes (1) Nalorphine. (D) Narcotics-narcotic preparations Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any of the
following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth
below: (1) Not more than 1.8 grams of codeine per 100 milliliters
or not more than 90 milligrams per dosage unit, with an equal or
greater quantity of an isoquinoline alkaloid of opium; (2) Not more than 1.8 grams of codeine per 100 milliliters
or not more than 90 milligrams per dosage unit, with one or more
active, nonnarcotic ingredients in recognized therapeutic
amounts; (3) Not more than 300 milligrams of dihydrocodeinone per
100 milliliters or not more than 15 milligrams per dosage unit,
with a fourfold or greater quantity of an isoquinoline alkaloid
of opium; (4) Not more than 300 milligrams of dihydrocodeinone per
100 milliliters or not more than 15 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts; (5) Not more than 1.8 grams of dihydrocodeine per 100
milliliters or not more than 90 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts; (6) Not more than 300 milligrams of ethylmorphine per 100
milliliters or not more than 15 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts; (7) Not more than 500 milligrams of opium per 100
milliliters or per 100 grams or not more than 25 milligrams per
dosage unit, with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts; (8) Not more than 50 milligrams of morphine per 100
milliliters or per 100 grams, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts. (E) Anabolic steroids Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances, including their salts, esters, isomers,
and salts of esters and isomers, whenever the existence of these
salts, esters, and isomers is possible within the specific
chemical designation: (1) Anabolic steroids. Except as otherwise provided in
division (E)(1) of schedule III, "anabolic steroids" means any
drug or hormonal substance that is chemically and
pharmacologically related to testosterone (other than estrogens,
progestins, and corticosteroids) and that promotes muscle growth.
"Anabolic steroids" does not include an anabolic steroid that is
expressly intended for administration through implants to cattle
or other nonhuman species and that has been approved by the
United States secretary of health and human services for that
administration, unless a person prescribes, dispenses, or
distributes this type of anabolic steroid for human use.
"Anabolic steroid" includes, but is not limited to, the
following: (a) Boldenone; (b) Chlorotestosterone (4-chlortestosterone); (c) Clostebol; (d) Dehydrochlormethyltestosterone; (e) Dihydrotestosterone (4-dihydrotestosterone); (f) Drostanolone; (g) Ethylestrenol; (h) Fluoxymesterone; (i) Formebulone (formebolone); (j) Mesterolone; (k) Methandienone; (l) Methandranone; (m) Methandriol; (n) Methandrostenolone; (o) Methenolone; (p) Methyltestosterone; (q) Mibolerone; (r) Nandrolone; (s) Norethandrolone; (t) Oxandrolone; (u) Oxymesterone; (v) Oxymetholone; (w) Stanolone; (x) Stanozolol; (y) Testolactone; (z) Testosterone; (aa) Trenbolone; (bb) Any salt, ester, isomer, or salt of an ester or
isomer of a drug or hormonal substance described or listed in
division (E)(1) of schedule III if the salt, ester, or isomer
promotes muscle growth. (F) Hallucinogenic substances (1) Dronabinol (synthetic) in sesame oil and encapsulated
in a soft gelatin capsule in a United States food and drug
administration approved drug product (some other names for
dronabinol:
(6aR-trans)-6a,7,8,10a-tetrahydro-
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
or
(-)-delta-9-(trans)-tetrahydrocannabinol). SCHEDULE IV(A) Narcotic drugs Unless specifically excepted by federal drug abuse control
laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any of the
following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth
below: (1) Not more than one milligram of difenoxin and not less
than 25 micrograms of atropine sulfate per dosage unit; (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-
1,2-diphenyl-3-methyl-2-propionoxybutane)[final dosage forms]. (B) Depressants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances, including their salts, isomers, and
salts of isomers, whenever the existence of these salts, isomers,
and salts of isomers is possible within the specific chemical
designation: (1) Alprazolam; (2) Barbital; (3) Bromazepam; (4) Camazepam; (5) Chloral betaine; (6) Chloral hydrate; (7) Chlordiazepoxide; (8) Clobazam; (9) Clonazepam; (10) Clorazepate; (11) Clotiazepam; (12) Cloxazolam; (13) Delorazepam; (14) Diazepam; (15) Estazolam; (16) Ethchlorvynol; (17) Ethinamate; (18) Ethyl loflazepate; (19) Fludiazepam; (20) Flunitrazepam; (21) Flurazepam; (22) Halazepam; (23) Haloxazolam; (24) Ketazolam; (25) Loprazolam; (26) Lorazepam; (27) Lormetazepam; (28) Mebutamate; (29) Medazepam; (30) Meprobamate; (31) Methohexital; (32) Methylphenobarbital (mephobarbital); (33) Midazolam; (34) Nimetazepam; (35) Nitrazepam; (36) Nordiazepam; (37) Oxazepam; (38) Oxazolam; (39) Paraldehyde; (40) Petrichloral; (41) Phenobarbital; (42) Pinazepam; (43) Prazepam; (44) Quazepam; (45) Temazepam; (46) Tetrazepam; (47) Triazolam; (48) Zaleplon; (49) Zolpidem. (C) Fenfluramine Any material, compound, mixture, or preparation that
contains any quantity of the following substances, including
their salts, their optical isomers, position isomers, or
geometric isomers, and salts of these isomers, whenever the
existence of these salts, isomers, and salts of isomers is
possible within the specific chemical designation: (1) Fenfluramine. (D) Stimulants Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances having a stimulant effect on the central
nervous system, including their salts, their optical isomers,
position isomers, or geometric isomers, and salts of these
isomers, whenever the existence of these salts, isomers, and salts
of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Mazindol; (6) Mefenorex; (7) Modafinil; (8) Pemoline (including organometallic complexes and
chelates thereof); (8)(9) Phentermine;
(9)(10) Pipradrol;
(10)(11) Sibutramine;
(12) SPA
[(-)-1-dimethylamino-1,2-diphenylethane]. (E) Other substances Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any quantity of
the following substances, including their salts: (1) Pentazocine; (2) Butorphanol (including its optical isomers). SCHEDULE V(A) Narcotic drugs Unless specifically excepted under federal drug abuse
control laws or unless listed in another schedule, any material,
compound, mixture, or preparation that contains any of the
following narcotic drugs, and their salts, as set forth below: (1) Buprenorphine. (B) Narcotics-narcotic preparations Narcotic drugs containing non-narcotic active medicinal
ingredients. Any compound, mixture, or preparation that contains
any of the following narcotic drugs, or their salts calculated as
the free anhydrous base or alkaloid, in limited quantities as set
forth below, and that includes one or more nonnarcotic active
medicinal ingredients in sufficient proportion to confer upon the
compound, mixture, or preparation valuable medicinal qualities
other than those possessed by narcotic drugs alone: (1) Not more than 200 milligrams of codeine per 100
milliliters or per 100 grams; (2) Not more than 100 milligrams of dihydrocodeine per 100
milliliters or per 100 grams; (3) Not more than 100 milligrams of ethylmorphine per 100
milliliters or per 100 grams; (4) Not more than 2.5 milligrams of diphenoxylate and not
less than 25 micrograms of atropine sulfate per dosage unit; (5) Not more than 100 milligrams of opium per 100
milliliters or per 100 grams; (6) Not more than 0.5 milligram of difenoxin and not less
than 25 micrograms of atropine sulfate per dosage unit. (C) Stimulants Unless specifically exempted or excluded under federal drug
abuse control laws or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any
quantity of the following substances having a stimulant effect on
the central nervous system, including their salts, isomers, and
salts of isomers: (1) Ephedrine, except as provided in division (K) of section 3719.44 of the
Revised Code; (2) Pyrovalerone. SECTION 2 . That existing section 3719.41 of the Revised Code is hereby
repealed.
|